against in Medical Technology

GAA Calls on Secretary Clinton to Speak Out Against Gender-Based Violence During Her Africa Trip

WASHINGTON, July 31 /PRNewswire-USNewswire/ -- Global AIDS Alliance executive director Dr. Paul Zeitz issued the following statement today on the eve of Secretary of State Hillary Clinton's departure for a seven-nation tour of Africa: "We applaud Secretary Clinton's decision to ...

Clay Walker's Band Against MS Foundation Donates $150,000 To Support Multiple Sclerosis Research

NASHVILLE, Tenn., July 6 /PRNewswire/ -- A Pebble Beach golf tournament pays off big for researchers looking for a cure for multiple sclerosis. The researchers took home the top prize: a $150,000 contribution from multi-platinum recording artist Clay Walker and the non-profit Band Against MS (BA...

CEL SCI Collaborators Demonstrate Novel L.E.A.P.S. Vaccines Immunize Mice Against Tuberculosis Antigens and Suggest Potential to Treat Swine and Other Influenzas

VIENNA, Va., June 5 /PRNewswire-FirstCall/ -- CEL-SCI Corporation (NYSE AMEX: CVM ) announced today that its collaborators at the University of Hawaii reported on data at the annual American Society for Microbiology in Philadelphia, PA. This data demonstrates that vaccines utilizing its L.E.A...

IMPACT Study Showed Longer Valcyte(R) (valganciclovir hydrochloride tablets) Treatment Demonstrated Better Protection Against Cytomegalovirus (CMV) Disease One Year Post-Transplant

CMV is the most serious viral infection affecting transplant patients BOSTON, June 1 /PRNewswire/ -- New Phase III study results presented for the first time today at the ninth annual American Transplant Congress 2009 (ATC) demonstrate that doubling the duration of preventive therapy ('prop...

Novel Vaccine Approach Offers Hope in Fight Against HIV

--Gene Transfer Technology May Lead to an HIV Vaccine-- PHILADELPHIA, May 17 /PRNewswire-USNewswire/ -- A research team may have broken the stubborn impasse that has frustrated the invention of an effective HIV vaccine, by using an approach that bypasses the usual path followed by vaccine dev...

Cystic Fibrosis - Orphan Drug Designation for Innovative Treatment Against Lung Infections by Axentis Pharma AG

ZURICH, Switzerland, April 30 /PRNewswire/ -- An innovative treatment for infections of the respiratory tract in cystic fibrosis patients has received orphan drug designation in the US. Axentis Pharma of Zurich, Switzerland announced today that this sought-after designation has been granted to...

Doctors Urge Precaution to Shield Against Swine Flu

BLAUVELT, N.Y., April 28 /PRNewswire/ -- As world health authorities debate how to stop the new strain of potentially deadly swine flu spreading quickly across the globe, medical options are limited. The current strain is a mutant of H1N1, containing a unique combination of pig, bird and huma...

Progress Against Malaria and Other Infectious Diseases Among Highlights at Annual Vaccine Conference

BALTIMORE, April 27 /PRNewswire/ -- Global progress toward a malaria vaccine is among the key topics to be presented at the 12th Annual Conference on Vaccine Research (ACVR), sponsored by the National Foundation for Infectious Diseases (NFID) April 27-29, 2009 in Baltimore. The ACVR is the world's...

Micromet Presents Preclinical Data Showing Activity of Erbitux and Vectibix Based BiTE Antibodies against KRAS- and BRAF-mutated Human Colorectal Cancer Cells

Study Presented at 2009 AACR Meeting Highlights Potential Therapeutic Approach to Treat Patients Unresponsive to Erbitux and Vectibix DENVER, April 22 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI ), a biopharmaceutical company developing novel, proprietary antibodies for the treat...

Pistachios Offer Protective Benefits Against Heart Disease, Type II Diabetes and Obesity

Research Presented at Experimental Biology 2009 Reveals Cardiovascular and Glycemic Control Benefits of Pistachios NEW ORLEANS, April 22 /PRNewswire/ -- Pistachios are much more than a great-tasting snack. The little green nuts may do more for your heart, blood sugar and waistline than many ...

Processed Tomato Products May Protect Against Inflammation, According to a Study Presented at the Experimental Biology Meeting

SACRAMENTO, Calif., April 21 /PRNewswire-USNewswire/ -- Tomato products may protect against inflammation. Such were the findings from a recent multi-center, randomized, controlled trial on the effects of processed tomatoes on vasodilatation and C-reactive protein in overweight and obese men and w...

Muscadine Grape Skin Dietary Supplement Protects against Cancer Therapy Radiation Side Effects

LEWISVILLE, N.C., April 20 /PRNewswire/ -- Muscadine grape skin powder, from Muscadine Naturals, Inc , (http:// www.muscadinenaturals.com /), provided significant protection against radiation damage in an independent study conducted on mice. The finding was reported in April of 2009 at the 1...

New Treatment Against Osteoarthritis: Orthokine Therapy Highly Effective Against Knee Arthritis After Two Years

DÿSSELDORF, Germany, February 23 /PRNewswire/ -- An international team of researchers has evaluated the effectiveness of Orthokine therapy for osteoarthritis of the knee, and the results have been published in the February edition of the specialist journal "Osteoarthritis and Cartilage". The ...

Shareholder Class Action Filed Against Rigel Pharmaceuticals, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP

RADNOR, Pa., Feb. 20 /PRNewswire/ -- The following statement was issued today by the law firm of Barroway Topaz Kessler Meltzer & Check, LLP: Notice is hereby given that a class action lawsuit was filed in the United States District Court for the Northern District of California on behalf ...

Sanofi Pasteur Starts a Phase II Study of a Vaccine Against Clostridium Difficile

LYON, France, February 17 /PRNewswire-FirstCall/ -- Sanofi Pasteur, the vaccines division of sanofi-aventis Group (EURONEXT : SAN and NYSE : SNY), announced today that it is sponsoring a phase II clinical study of a vaccine against Clostridium difficile, which is among the most common causes o...

Micromet Presents Data at the 23rd Annual Meeting of the International Society for Biological Therapy of Cancer on the Activity of Human Antibody Adecatumumab against KRAS-mutated Colon Cancer Cells

BETHESDA, Md., Nov. 4 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, presented data from a preclinical study(1) showing cytotoxic activity of anti-E...

New Data Show In Vitro Potency of Doripenem Against Resistant Bacteria

WASHINGTON, Oct. 27 /PRNewswire/ -- Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD), today announced new study results that demonstrate doripenem (DORIBAX(TM), doripenem for injection), a carbapenem antibiotic, was found to be more potent in vitro against certain strai...

Local Research Foundation Achieves Milestone in Fight Against Cancer

CHRISTUS Stehlin Foundation for Cancer Research Develops Innovative Anticancer Drug HOUSTON, Oct. 23 /PRNewswire/ -- Almost everyone knows the devastation that cancer brings to families, workplaces and communities, and many Houstonians are aware of well-known local...

Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy

Quark siRNAs Examined Alone and in Combination with Chemotherapy FREMONT, Calif. Oct. 12 /PRNewswire/ -- Quark Pharmaceuticals, Inc., a development-stage pharmaceutical company discovering and developing novel RNA interference (RNAi)-based therapeutics, today announced that the journal Cance...

Enanta Initiates Phase 1 Study on EDP-322, an Oral Antibiotic With Activity Against Hospital- and Community-Acquired MRSA

EDP-322 is a First-in-class MRSA-active Bicyclolide, a novel macrolide-related drug class WATERTOWN, Mass., Sept. 15 /PRNewswire/ -- Enanta Pharmaceuticals, a leader in the development of small molecule anti-infective drugs, announced today the initiation of a Phase ...

Study Demonstrates That AHCC(R) Provides Immune Enhancement Against the West Nile Virus

Proves promising for individuals living with West Nile Virus and populations susceptible such as the elderly or immune compromised PURCHASE, N.Y., Sept. 9 /PRNewswire/ -- A recently completed study from researchers at Colorado State University supported by the Division of Vector-Borne In...

Karolinska Institutet to Test Vical's Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control

SAN DIEGO, Aug. 19 /PRNewswire-FirstCall/ -- Vical Incorporated (Nasdaq: VICL ) today announced a research collaboration with the Karolinska Institutet (KI), a leading European medical university, and the Swedish Institute for Infectious Disease Control (SMI), a governmental expert agency, to...

Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control

SAN DIEGO, Aug. 19 /PRNewswire-FirstCall/ -- Vical Incorporated (Nasdaq: VICL ) today announced a research collaboration with the Karolinska Institute, a leading European medical university, and the Swedish Institute for Infectious Disease Control (SMI), a governmental expert agency, to evalu...

Two New Alzheimer's Disease Studies Show Advances Against Different Treatment Targets

- Plus, Higher then Expected MCI Prevalence Shows Urgent Need for Better Therapies - CHICAGO, July 28 /PRNewswire-USNewswire/ -- Two studies related to experimental Alzheimer's therapies reported positive results today at the 2008 Alzheimer's Association International Conference on Alzheimer...

Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus

Study Demonstrates Feasibility and Efficacy of Treating Patients with Primary Liver Cancer SAN FRANCISCO, and YONGIN-SI, South Korea, July 22 /PRNewswire/ -- Jennerex, Inc. (San Francisco, CA and Ottawa, Ontario), and its South Korean partner Green Cross Corp., announ...

Novel Approach May Protect Against Heart Attack Injury

- Drugs Target Gene Pathways to Preserve Heart, Possibly Other Organs - PHILADELPHIA, July 10 /PRNewswire-USNewswire/ -- Researchers at The Children's Hospital of Philadelphia have manipulated cell activity that occurs during the interruption of blood flow to strongly protect heart tissue in...

Grocery Manufacturers Association: Study Signals Progress in Battle Against Obesity

WASHINGTON, May 28 /PRNewswire-USNewswire/ -- Robert Brackett, chief science officer for the Grocery Manufacturers Association (GMA), today released the following statement in response to the findings on childhood and teen obesity rates reported in the latest issue of the Journal of the Americ...

Lixte Biotechnology Holdings Announces That Anti-Cancer Activity Against Glioblastoma in an Animal Model Was Reported at the Annual Meeting of the American Association of Cancer Research

EAST SETAUKET, N.Y., April 23 /PRNewswire-FirstCall/ -- Lixte Biotechnology Holdings (OTC Bulletin Board: LIXT) announced today that Dr. Jie Lu and Dr. Zhengping Zhuang of the Surgical Neurology Branch (SNB), National Institute of Neurological Disorders and Stroke (NINDS), National Institutes ...

Shareholder Class Action Filed Against Vertex Pharmaceuticals Incorporated by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP

RADNOR, Pa., April 18 /PRNewswire/ -- The following statement was issued today by the law firm of Schiffrin Barroway Topaz & Kessler, LLP: Notice is hereby given that a class action lawsuit was filed in the United States District Court for the District of Massachusetts on behalf of all purch...

NOLabs AB Reports Success in Fight Against Bacteria Causing Urinary Tract Infection

HELSINGBORG, Sweden, April 15 /PRNewswire/ -- NOLabs AB, the Swedish medtech company focusing on developing innovative Nitric Oxide-containing medical devices, today reported that it has achieved another important milestone in the development of a new preventive therapy against urinary tract i...

VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy

- Post-unblinding analysis of MA-17 trial data provides evidence for potential benefit of starting Femara up to seven years after finishing tamoxifen - Femara only member of aromatase inhibitor class with data demonstrating this potential benefit, as publishe...

Parker Waichman Alonso LLP and Affiliated Lawfirms Have Filed a Class Action Lawsuit in the United States District Court for the Eastern District of New York Against Merck & Co., Inc. and Schering-Plough Corporation

Great Neck, N.Y., Jan. 18 /PRNewswire/ -- On January 17, 2008, the law firms of Parker Waichman Alonso LLP, Becnel Law Firm, LLC, Douglas & London P.C., Levin Simes Kaiser and Gornick LLP, Bailey Perrin Bailey LLP and Weitz & Luxenberg, P.C., have filed over a Billion ($1,000,000,000) Dollar C...

New Data Published in The Lancet Show GSK's ROTARIX(R) Offers Protection Against the Most Common Circulating Rotavirus Types

Protection Sustained During the First Two Years of Life PHILADELPHIA, Nov. 23 /PRNewswire-FirstCall/ -- New data from a large European clinical trial published today in The Lancet show ROTARIX(R), GlaxoSmithKline's (NYSE: GSK ) oral rotavirus candidate vaccine to prevent rotavirus gas...

Actress and Mother Jennifer Garner Kicks Off American Lung Association's Faces of Influenza Awareness Campaign, Encouraging Families to Get Vaccinated Against Influenza

NEW YORK, Nov. 12 /PRNewswire-USNewswire/ -- Actress Jennifer Garner joined leading medical officials at a press conference today to kick off the American Lung Association's national Faces of Influenza public awareness campaign, urging Americans to get their annual influenza vaccination. The p...

Pharmaceutical Companies Lead Fight Against Staph and Other Infectious Diseases

WASHINGTON, Nov. 6 /PRNewswire-USNewswire/ -- A new report released today by the Pharmaceutical Research and Manufacturers of America (PhRMA) finds that America's pharmaceutical research companies are now testing 338 new medicines to help treat infectious diseases, including 11 medicines and f...

BD and PEPFAR Collaborate to Strengthen Laboratory Systems in Fight Against HIV/AIDS and TB

Public-Private Partnership Valued up to $18 Million over Five Years WASHINGTON and FRANKLIN LAKES, N.J., Oct. 31 /PRNewswire-FirstCall/ -- The U.S. President's Emergency Plan for AIDS Relief (Emergency Plan/PEPFAR) joined BD (Becton, Dickinson and Company) to announce the signing of a Memora...

Semafore's PI3 Kinase Inhibitor SF1126 is Active Against Tumor and Tumor Cells and Synergizes with Standard Chemotherapy Agents

SAN FRANCISCO, Oct. 26 /PRNewswire/ -- Semafore Pharmaceuticals Inc. announced today on the occasion of a poster presentation at the 2007 AACR-NCI- EORTC International Conference in San Francisco that its integrin-targeted PI3 kinase inhibitor, SF1126, showed synergistic effects with certain s...

Jennerex Presents Clinical Data From JX-594 Demonstrating Tumor Efficacy Against Advanced Liver Cancers

Positive Results Prompt Phase 2 Trial of JX-594 in Liver and Head and Neck Cancers SAN FRANCISCO, Oct. 23 /PRNewswire/ -- Jennerex Biotherapeutics today presented clinical data from a Phase 1 / 2 trial of JX-594 -- the company's proprietary targeted lytic and immu...

Roche Announces Positive Results in Solid Tumors Using Human Monoclonal Antibody Against IGF-1R (R1507)

NUTLEY, N.J., Oct. 23 /PRNewswire/ -- Today, Roche announced positive results from a Phase I trial of R1507, a human monoclonal antibody to target IGF-1R (insulin-like growth factor receptor), in patients with solid tumors. IGF-1 is one of the most potent natural activators of the AKT and MAPK...

Interim Safety Data Favorable for Vical's Phase 2 Trial of DNA Vaccine Against CMV

SAN DIEGO, Oct. 17 /PRNewswire-FirstCall/ -- Vical Incorporated (Nasdaq: VICL ) today announced that an independent data safety monitoring board (DSMB) found no safety issues and recommended continuation of the company's Phase 2 trial of a DNA vaccine against cytomegalovirus (CMV). The DSMB c...